Stats: $50 rise in out-of-pocket costs tied to lower neurologic meds use

As out-of-pocket costs surge for drugs for the neurologic disorders Alzheimer's disease, peripheral neuropathy and Parkinson's disease, people are less likely to take the drugs as often as their doctors prescribe, a recent study reveals. Study author Brian C. Callaghan, MD, of the University of Michigan in Ann Arbor commented, "Of course, if people do not follow their prescriptions correctly, they are less likely to benefit from the drug and see improvements in their condition, possibly leading to complications and higher costs later." Industry professionals need to be aware that not taking medications regularly can also trigger symptoms, potentially affecting an individual's ability to participate in programs or leading to disruptions in group activities